🇺🇸 FDA
Patent

US 7521063

Multiple CPG oligodeoxynucleotides and their use to induce an immune response

granted A61KA61K2039/55561A61P

Quick answer

US patent 7521063 (Multiple CPG oligodeoxynucleotides and their use to induce an immune response) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/55561, A61P, A61P31/04, A61P31/10